Viewing Study NCT03811457


Ignite Creation Date: 2025-12-24 @ 6:47 PM
Ignite Modification Date: 2026-01-11 @ 9:34 AM
Study NCT ID: NCT03811457
Status: COMPLETED
Last Update Posted: 2019-01-22
First Post: 2019-01-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Immunotherapy With CD19 CAR T-cells in Patients With Relapsed or Refractory CD19+ Leukemia and Lymphoma
Sponsor: UWELL Biopharma
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module